Zhang Yan, Wang Zhongqiu, Liu Jun, Zhang Zhenyu, Chen Ye
State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, 1838 North Guangzhou Road, Guangzhou, Guangdong 510515, China; Department of Gastroenterology, First Affiliated Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China.
Department of Radiation Oncology and Cyberknife Center, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Gastroenterol Res Pract. 2016;2016:6421351. doi: 10.1155/2016/6421351. Epub 2016 Aug 8.
Syndecan-1 (SDC1), with a long variable ectodomain carrying heparan sulfate chains, participates in many steps of inflammatory responses. But reports about the efforts of SDC1's unshedding ectodomain on intestinal epithelial inflammation and the precise underlying mechanism are limited. In our study, unshedding SDC1 from intestinal epithelial cell models was established by transfecting with unshedding SDC1 plasmid into the cell, respectively. And the role of unshedding SDC1 in intestinal inflammation was further investigated. We found that components of NF-κB pathway, including P65 and IκBα, and secretion of TNF-α were upregulated upon LPS stimulation in intestinal epithelial cells. SDC1, especially through its unshed ectodomain, significantly lessened the upregulation extent. It also functioned in inhibiting migration of neutrophils by downregulating secretion of CXCL-1. Taken together, we conclude that suppressing SDC1 shedding from intestinal epithelial cells relieves severity of intestinal inflammation by inactivating NF-κB pathway and downregulating TNF-α expression. These results indicate that the ectodomain of SDC1 might be the optional therapy for intestinal inflammation.
Syndecan-1(SDC1)具有一个携带硫酸乙酰肝素链的长可变胞外域,参与炎症反应的多个步骤。但关于SDC1未脱落的胞外域对肠道上皮炎症的作用及确切潜在机制的报道有限。在我们的研究中,通过分别将未脱落SDC1质粒转染到细胞中,建立了肠道上皮细胞模型中未脱落SDC1的模型。并进一步研究了未脱落SDC1在肠道炎症中的作用。我们发现,在肠道上皮细胞中,脂多糖刺激后,NF-κB通路的成分,包括P65和IκBα,以及TNF-α的分泌上调。SDC1,尤其是通过其未脱落的胞外域,显著降低了上调程度。它还通过下调CXCL-1的分泌来抑制中性粒细胞的迁移。综上所述,我们得出结论,抑制肠道上皮细胞中SDC1的脱落可通过使NF-κB通路失活和下调TNF-α表达来减轻肠道炎症的严重程度。这些结果表明,SDC1的胞外域可能是肠道炎症的可选治疗方法。